Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

720,000 IU/kg intravenous (IV) every eight hours (+/- 1 hour) beginning within 24 hours of cell infusion and continuing for up to 4 days (maximum 12 doses).

25 mg/m\^2/day intravenous piggy-back (IVPB) daily for 5 days

30 mg/kg/day intravenous piggy-back (IVPB) daily for 3 days.

60 mg/kg/day X 2 days intravenous (IV)

Days -5 to -3 (low-dose arm):30 mg/kg IV over 60 minutes for 2 days

Days -5 to -3 (low-dose arm): 300 mg/m\^2 IV over 60 minutes.

Day 0: Cells will be infused intravenously (IV)

2 mg/kg intravenous (IV) on Days -2, 21 (+/- 2 days), 42 (+/- 2 days), and 63 (+/- 2 days).